Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review (P4-12.001). Blumenfeld A, Mechtler L, Cook L, Rhyne C, et al. Neurology 2024;102.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blumenfeld A, Mechtler L, Cook L, Rhyne C, et al. Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review (P4-12.001). Neurology 2024;102.
PMID: 39977883